Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease

Abstract

Background & Aims Hepatocellular carcinoma (HCC) can develop in individuals without cirrhosis. We investigated risk factors for development of HCC in the absence of cirrhosis in a US population. Methods We identified a national cohort of 1500 patients with verified HCC during 2005–2010 in the US Veterans Administration (VA), and reviewed their full VA medical records for evidence of cirrhosis and risk factors for HCC. Patients without cirrhosis were assigned to categories of level 1 evidence for no cirrhosis (very high probability) or level 2 evidence for no cirrhosis (high probability), based on findings from histologic analyses, laboratory test results, markers of fibrosis from non-invasive tests, and imaging features. Results A total of 43 (2.9%) of the 1500 patients with HCC had level 1 evidence for no cirrhosis and 151 (10.1%) had level 2 evidence for no cirrhosis; the remaining 1203 patients (80.1%) had confirmed cirrhosis. Compared to patients with HCC in presence of cirrhosis, greater proportions of patients with HCC without evidence of cirrhosis had metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), or no identifiable risk factors. Patients with HCC without evidence of cirrhosis were less likely to have abused alcohol or have HCV infection than patients with cirrhosis. Patients with HCC and NAFLD (unadjusted odds ratio, 5.4; 95% confidence interval, 3.4–8.5) or metabolic syndrome (unadjusted odds ratio, 5.0; 95% confidence interval, 3.1–7.8) had more than a 5-fold risk of having HCC in the absence of cirrhosis, compared to patients with HCV-related HCC. Conclusions Approximately 13% of patients with HCC in the VA system do not appear to have cirrhosis. NAFLD and metabolic syndrome are the main risk factors HCC in the absence of cirrhosis.

Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort

“…Two hepatologists (HES, SM) manually reviewed the EMR including imaging reports, laboratory tests, and physician notes within the 2 years prior to the HCC diagnosis date to determine receipt of HCC surveillance, presence or absence of cirrhosis, and recognition of cirrhosis status by providers [20,21]. We defined HCC surveillance by receipt of at least one liver imaging test with or without AFP for surveillance purposes within 2 years prior to HCC diagnosis date.…”

Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations

“…Thirteen percent of patients with NAFLD and especially NASH experience increased mortality risk due to liver disease, 25% due to cardiovascular disease, and 28% due to liver cancer such as hepatocellular carcinoma (HCC) [4]. In the absence of cirrhosis, the main risk factors for HCC are NAFLD and MetS [48]…”

Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease

“…Hepatocellular carcinoma (HCC) can develop in the absence of cirrhosis,2 and patients with NAFLD have an increased risk of HCC3 4. NASH is the second-leading indication for liver transplantation, but will likely become the leading cause in 2020 5…”